WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study

BACKGROUND: Cutaneous leishmaniasis (CL) is a disfiguring disease that confronts clinicians with a quandary: leave patients untreated or engage in a complex or toxic treatment. Topical treatment of CL offers a practical and safe option. Accordingly, the treatment of CL with WR279,396, a formulation...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ben Salah, Afif, Buffet, Pierre A., Morizot, Gloria, Ben Massoud, Nathalie, Zâatour, Amor, Ben Alaya, Nissaf, Haj Hamida, Nabil Bel, Ahmadi, Zaher El, Downs, Matthew T., Smith, Philip L., Dellagi, Koussay, Grögl, Max
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2009
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2673687/
https://ncbi.nlm.nih.gov/pubmed/19415122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0000432
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller